Executive pay

Recursion Pharmaceuticals (RXRX) executive compensation

What Recursion Pharmaceuticals, Inc. paid its chief executive and named officers, year by year. Figures are automated and can be wrong; check the filing for the exact numbers.

  • 2026 proxy statement

    Christopher Gibson paid $9.6M (+13% on the year), pay ratio 33:1.

    Filed Apr 30, 2026